Gene Expression Changes from Comfrey and Riddelliine in Rat Liver
Author Information
Author(s): Guo Lei, Mei Nan, Dial Stacey, Fuscoe James, Chen Tao
Primary Institution: Division of Systems Toxicology, National Center for Toxicological Research, FDA
Hypothesis
Pyrrolizidine alkaloids (PAs) contained in comfrey are the main active components responsible for carcinogenicity.
Conclusion
The carcinogenesis-related gene expression patterns resulting from the treatments of comfrey and riddelliine are very similar, indicating that PAs are the main active components responsible for the carcinogenicity of comfrey.
Supporting Evidence
- Comfrey has been used for over 2000 years but is known to be hepatotoxic and carcinogenic.
- The study found that both comfrey and riddelliine altered gene expressions related to cancer.
- A total of 1814 genes were altered by comfrey treatment, compared to 639 by riddelliine.
Takeaway
This study looked at how two substances, comfrey and riddelliine, affect genes in rat livers. It found that both can change similar genes that are linked to cancer.
Methodology
Rats were treated with either comfrey or riddelliine for 12 weeks, and gene expression was analyzed using microarrays.
Limitations
The study does not clarify the specific mechanisms of tumor induction by comfrey due to its complex mixture of substances.
Participant Demographics
Big Blue Fisher 344 rats were used in the study.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website